TodayWednesday, November 18, 2026

Pet Care Costs Hang In The Balance As FTC And 12 States Move To Dismantle $3.5B Vet Supply Merger

A $3.5 billion deal that would reshape how veterinary clinics across the United States source drugs, vaccines, and equipment is now facing a federal court battle.

The Federal Trade Commission, backed by a bipartisan coalition of 12 state attorneys general, filed suit in New York federal court to prevent Covetrus from absorbing MWI Animal Health, a unit of Cencora Inc. (COR).

The February 2026 transaction was structured so that Cencora would receive $1.25 billion in cash, $800 million in preferred stock, and $1.45 billion in common equity from Covetrus and its private equity backers.

Those backers, Clayton, Dubilier and Rice and TPG Inc. (TPG), are named alongside Covetrus Inc. and Cencora in the complaint as parties the government wants stopped from closing the deal.

Regulators argue that Covetrus and MWI currently serve as each other’s most direct competitors, fighting for veterinary clients through aggressive discounts, rebates, and service incentives.

Folding that rivalry into a single corporate entity, the FTC contends, would remove the competitive pressure that keeps costs manageable for independent clinics and large veterinary chains alike.

States joining the lawsuit include California, New York, Texas, Arizona, Arkansas, Colorado, Maine, Michigan, Nebraska, North Carolina, Ohio, and Oregon, reflecting broad geographic concern about pricing in the companion animal sector.

The agency warned that pet owners, not just veterinary practices, would ultimately absorb higher costs if the two largest national distributors of veterinary products were allowed to consolidate.

MWI supplies vet practices and livestock producers with pharmaceuticals, vaccines, and equipment, while Covetrus layers in pharmacy services, technology tools, and practice-management software on top of distribution.

Covetrus pushed back sharply on the day the complaint was filed, with the company characterizing the agency’s position as “narrow and outdated” and signaling a willingness to litigate.

The company argues that veterinary clinics retain meaningful alternatives, including direct purchasing from manufacturers, competing distributors, and online marketplaces that the FTC’s framing allegedly ignores.

Covetrus also maintains that integrating the two operations would produce distribution efficiencies capable of lowering the overall cost of supplying veterinary practices across the country.

The burden now falls on Covetrus and its private equity sponsors to persuade a federal judge that customers have credible switching options sufficient to constrain pricing after any combination.

Should the government prevail, MWI Animal Health would remain a subsidiary of Cencora unless the companies choose to pursue an entirely different strategic arrangement.

Jordan Hayes

Jordan Hayes is a seasoned business reporter at iBusiness.News, specializing in market trends, corporate developments, and financial technology. With a keen eye for detail and a passion for breaking down complex business topics, Jordan delivers insightful coverage that keeps readers informed and ahead of the curve.

Before joining iBusiness.News, Jordan contributed to several financial publications, honing expertise in global markets and emerging industries.